RT Journal Article
SR Electronic
T1 Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10
JF Anticancer Research
JO Anticancer Res
FD International Institute of Anticancer Research
SP 635
OP 640
DO 10.21873/anticanres.13157
VO 39
IS 2
A1 ARISA KUMAGAI-TOGASHI
A1 HIROSHI UOZAKI
A1 YOSHINAO KIKUCHI
A1 SHIORI WATABE
A1 SATOE NUMAKURA
A1 MASATO WATANABE
YR 2019
UL http://ar.iiarjournals.org/content/39/2/635.abstract
AB Background/Aim: CD10 function in urothelial carcinoma (UC) remains controversial. We previously reported that miR-21 in UC may be a prognostic marker for cancer progression. The aim of this study was to examine the clinicopathological significance of CD10 expression in UC and its relationship with miR-21 expression. Materials and Methods: Immunohistochemistry for CD10 was performed on 232 UCs. CD10 expression in TCs and stroma was evaluated respectively, and its association with carcinogenesis and survival was analyzed. Results: High tumorous CD10 was significantly associated with higher tumor stage, histological grade and vessel infiltration, and poorer prognosis, whereas stromal CD10 was significantly associated with younger age, higher tumor stage, and vessel infiltration. On multivariable analysis, CD10 expression in TCs, miR-21 expression in TCs and TS, and tumor stage were independent prognostic factors. Conclusion: Tumorous CD10 is more strongly related to progression of UC than stromal CD10 and is an independent factor for UC prognosis.